跳至主要内容
临床试验/CTRI/2019/07/020023
CTRI/2019/07/020023已完成1 期

Randomized controlled trial of ââ?¬Å? Ajmodadi churna vatiââ?¬? as an add-on effect in the management of Madhumeha.

Sumatibhai Shah Ayurved Mahavidyalaya0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.A known Diabetic on treatment and a newly diagnosed Diabetes.
  • 2.Patient with fasting blood sugar up to 220 mg% and post prandial blood sugar up to 300 mg%.
  • 3.Patient having HbA1C upto 10.
  • 4.If the patient is taking ayurvedic medicine for Madhumeha, Washout period for them will be 8 days.

排除标准

  • 1.Patients with fasting blood sugar above 220 mg% and post prandial blood sugar above 300mg%.
  • 2.Patient who is already taking Ayurvedic management for Madhumeha.
  • 3.Diabetes Mellitus Type-I ,Acromegaly, Cushingââ?¬•s syndrome and pancreatic disorder.
  • 4.Those who are under Insulin therapy.
  • 5.Pregnant and lactating mothers.
  • 6.Patients with acute complications like Hyperglycemic coma, Ketoacidosis and infections like gangrene.
  • 7.Patients with K/C/O Nephropathy, Neuropathy and Retinopathy.
  • 8.Patients with gastrointestinal diseases, Liver diseases, tumors, conditions like cardiovascular disease, acute myocardial infarction, immune-compromised disease(HIV)

研究者

发起方
Sumatibhai Shah Ayurved Mahavidyalaya

相似试验

Study of Ajmodadi churna Tablet in Diabetes. | 临床试验